GL1X · GenesisL1 explorer

Research workbench

Crystal structure of D-glucuronyl C5-epimerase in complex with heparin hexasaccharide

Analyse Crystal structure of D-glucuronyl C5-epimerase in complex with heparin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PXQ
Type
protein
Length
1,031 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
D-glucuronyl C5 epimerase B
EC
5.1.3.17
UniProt
Q6TS32
Ligands
UAP, SGN, IDS
Pockets
8 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AD-glucuronyl C5 epimerase B (EC 5.1.3.17)protein51632% helix, 27% strandQ6TS32
BD-glucuronyl C5 epimerase B (EC 5.1.3.17)protein51532% helix, 28% strandQ6TS32

Ligands and binding sites

  • UAP · 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronic acid · ligand · 2 copies · chains A, B
  • SGN · 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose · sugar · 6 copies · chains A, B
  • IDS · 2-O-sulfo-alpha-L-idopyranuronic acid · sugar · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12860.790.9144empty
22780.610.8043empty
33170.580.7740SGN, IDS, UAP
42570.580.7942empty
53040.570.7634SGN, IDS, UAP

Interfaces

1 interface between chains.

  • A–B · 3204 Ų buried · 55 hydrogen bonds · protein-protein

Compared structures

  • 4PXQ · Crystal structure of D-glucuronyl C5-epimerase in complex with heparin hexasaccharide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.